S. Khan

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

Scott A. Halperin, Lingyun Ye, Donna MacKinnon‐Cameron et al. · The Lancet · 2021 · 230 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein

S. Khan, Raymond T. Chung, Keith J. Cross · Carcinogenesis · 2010 · 167 citations · Full text

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination

Dominic G. Roy, Karen Geoffroy, Monique Marguerie et al. · Nature Communications · 2021 · 60 citations · Full text

Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy

Marie-Ève Wedge, Victoria A. Jennings, Mathieu J. F. Crupi et al. · Nature Communications · 2022 · 46 citations · Full text

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer

Mathieu J. F. Crupi, Zaid Taha, Thijs J. A. Janssen et al. · Frontiers in Immunology · 2022 · 29 citations · Full text